Medical Issues in the Management of Alzheimer Disease
Today an estimated 5.3 million Americans have Alzheimer disease. It is the 6th most common cause of death. Among the top causes of death, it is the only one with no
prevention or cure. The average per-person Medicare payments for services to beneficiaries age ≥65 years with AD and other dementias are more than two and a half
times as great as payments for all beneficiaries without these conditions, and Medicaid payments are 19 times as great. Between 2000 and 2013, deaths resulting from
heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, whereas deaths from AD increased 71%. The current 5.3 million people with AD
will grow to 11-16 million by 2050.
These statistics alone call the Primary Care Physician to action in the care of people with Alzheimer’s disease. We must develop medical management strategies to confront
this silent epidemic. Life styles, the metabolic syndrome, depression, stroke, anesthesia and surgeries appear to affect the age of onset and the progression of disease. Addressing these events may provide opportunities to improve care of people with dementia. Similarly the challenges of end of life such as nutrition, pain control and comorbidities present unique challenges for those with dementia.
This symposium will provide the primary care physician, specialist and allied health professional with opportunities of intervention in the medical management of people with
Alzheimer disease in order to improve their quality of life while a valid therapeutic intervention is being developed.
Please note: There will be a 4% processing fee assessed to all registrations.
All fees are non-refundable
At the conclusion of this activity, I will be able to:
- Participants will understand the relationship between medical risk factors like the metabolicsyndrome, depression, anesthesia, surgeries and dementia
- Adverse effects of commonly prescribed medications for management of behavior or medical comorbidities will be reviewed in order to provide the clinician with informed management strategies.
- Often the presence of vascular disease makes the diagnosis of Alzheimer disease difficult. The participant will be able to assess the different cerebrovascular syndromes which may contribute to dementia.
- End of life issues unique to dementia patients will be presented in the contest of common medical problem at the end of life such as pain control and nutrition and establishment of hospice care.
|Kirk Hogan, MD||Sonoplot, Inc.||Founder|
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
- 5.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 5.00 Hours of ParticipationHours of Participation credit.